Clarity Engagement Solutions

NOVEMBER 9, 2020

In this case, what is the issue for Pharma? Customer-facing account teams still try to develop business with a product-focused mentality at the same time that healthcare stakeholders wrestle with challenges; the timing and context of which, render product-centric approaches a distraction. . – Patient empowerment.

Pharma 91

Pharma Healthcare Healthcare Distribution 91

Clarity Engagement Solutions

NOVEMBER 9, 2020

Traditionally the pharma industry relied on the volume of prescriptions made. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process. Pharma and bio-tech companies need to adopt more innovative market access tactics to succeed.

Marketing 91

Marketing Key account management Pharma Prescription 91

Clarity Engagement Solutions

NOVEMBER 9, 2020

Traditionally the pharma industry relied on the volume of prescriptions made. the evolving healthcare industry, pharma and bio-tech companies are now focusing on each component of market access: – Price. – Government agencies. – Government agencies. – Channel. – Stakeholders. – Channel.

Marketing 91

Marketing Key account management Pharma Prescription 91

pharmaphorum

DECEMBER 23, 2022

Companies that adopt this blended model will be able to recognise performance gaps earlier and, for the first time, align incentives across the entire commercial ecosystem, including sales reps, key account managers, and medical science liaisons.”. Content automation will deliver as AI fails to live up to the hype.

Marketing 102

Marketing Sales Medical Patients 102

Evolve Your Success

JANUARY 31, 2023

You have to be able to talk about your product, especially in our field because it’s so governed by the FDA. Number one is if you want to make the transition from pharma to medical device, many people have gone back and forth. You’ve been in both pharma and med device. That is true. It’s litigious.

Medical sales 64

Medical sales Sales Medical Training 64